Onconetix, Inc. Servicing Liability at Fair Value, Amount
Onconetix, Inc. (ONCO) had Servicing Liability at Fair Value, Amount of $3.32 million as of 2025-03-31, per its 10-Q filed 2025-06-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ServicingLiabilityAtFairValueAmount · last filed 2025-06-12
- 2025-03-31: Servicing Liability at Fair Value, Amount $3.32M.
- 2024-03-31: Servicing Liability at Fair Value, Amount $226.00K.
- 2023-12-31: Servicing Liability at Fair Value, Amount $900.00K.
| Period end | Servicing Liability at Fair Value, Amount |
|---|---|
| 2025-03-31 | $3.32M 10-Q · filed 2025-06-12 |
| 2024-03-31 | $226.00K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $900.00K 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |